APOE and Parkinson disease: Because we demonstrated the difference between AD APOE ε4 carriers and non-carriers and because no risk genes were found in PD to play such a significant role as APOE ε4 in AD, the disparity could be attributed to the fact that the authors of the previous study did not stratify the AD samples according to APOE status.